HUTCHMED reported positive Phase 3 trial results for sovleplenib in autoimmune anemia, supporting a planned China drug filing ...
This news release constitutes a "designated news release" for the purposes of the Company's amended and restated prospectus ...
The northern lights, also known as the aurora borealis, are one of nature’s most captivating displays, appearing as ...
I just hit 20,000 steps!" my husband exclaims as he brags when his fitness tracker exceeds the oft-heard benchmark of 10,000 steps per day. Although I rarely get that many steps, I use my ...
Work starts around sunrise for many of the federal officers carrying out the immigration crackdown in and around the Twin ...
The Daily Yonder on MSN

Q&A: Communities Without Vital Data

This interview first appeared in Path Finders, an email newsletter from the Daily Yonder. Each week, Path Finders features a ...
The probation period for one of the biggest jobs in jump racing begins in Berkshire on a mid-January afternoon, and the boss ...
In a Phase 1 clinical study, researchers led by EPFL and their partners report that a new liver- and gut-targeted oral drug ...
Digitalizing supply chains helps firms boost green innovation by improving data visibility, coordination, and transparency ...
Five minutes into her first game in Tokyo, Emelia Beldon, ’22, grimaced as she laid facedown on the court. A hard foul by a ...